Editor: Yusuf Tutar

Advances in Cancer Nanotheranostics for Experimental and Personalized Medicine

eBook: US $69 Special Offer (PDF + Printed Copy): US $117
Printed Copy: US $83
Library License: US $276
ISBN: 978-981-14-5689-3 (Print)
ISBN: 978-981-14-5691-6 (Online)
Year of Publication: 2020
DOI: 10.2174/97898114569161200101

Introduction

Nanotheranostics is a recent medical field which integrates diagnostic imaging protocols and therapeutic functions to monitor real time drug release in the body and distribution to the target site. The combined processes allow technicians to observe the effectiveness of a specifically designed drug candidate and predict its possible side effects. All these features help clinicians in optimizing treatment options for cancer and other diseases for the individual patient. Current research is tailored to individual therapy because each drug may display a variety of responses depending on variations in an individual’s genetics and subsequently, their clinical biochemistry. Many tumors are still challenging for therapists in terms of available treatment and nanotheranostic strategies may help them to combat cancer more efficiently.

Advances in Cancer Nanotheranostics for Experimental and Personalized Medicine presents information about current theranostic technologies in use at clinics and recent research on nanotheranostic applications, with a focus on cancer treatment. Information is presented in seven organized chapters that cover the basics of cancer nanotheranostics, tumor microenvironmental factors, gene therapy and gene delivery concepts, and the combined application of diagnostic imaging with cancer chemotherapy. A chapter focusing on the role of non-coding MRNAs in breast cancer carcinogenesis is also included, giving readers a glimpse of the complexities in the molecular biology of cancer which drive the need for new theranostic technologies. The book is of interest to medical professionals (including oncologists and specialists in internal medicine), diagnostic imaging technicians, and researchers in the fields of pharmacology, molecular biology and nuclear medicine.

Contributors

Editor(s):
Yusuf Tutar




Contributor(s):
Ezgi Nurdan Yenilmez Tunoglu
University of Health Sciences
Hamidiye Health Sciences Institute, Division of Molecular Medicine, 34668
Istanbul
Turkey


Berçem Yeman
University of Health Sciences
Hamidiye Health Sciences Institute, Division of Molecular Medicine, 34668
Istanbul
Turkey


Merve Biçen
University of Health Sciences
Hamidiye Health Sciences Institute, Division of Molecular Medicine, 34668
Istanbul
Turkey


Servet Tunoglu
Department of Molecular Medicine
Aziz Sancar Institute of Experimental Medicine
Istanbul University, 34093, Istanbul
Turkey


Yousef Rasmı
Department of Biochemistry
Faculty of Medicine, Urmia University of Medical Sciences
571478334, Urmia
Iran


Yusuf Tutar
University of Health Sciences
Hamidiye Health Sciences Institute, Division of Molecular Medicine, 34668
Istanbul
Turkey
/
University of Health Sciences
Hamidiye Faculty of Pharmacy, Department of Basic Pharmaceutical Sciences, Division of Biochemistry
34668, Istanbul
Turkey


Raghda Ashraf Soliman
Pharmaceutical Biology Department
Faculty of Pharmacy and Biotechnology, German University in Cairo
11835, Cairo
Egypt


Rana Ahmed Youness
Pharmaceutical Biology Department
Faculty of Pharmacy and Biotechnology, German University in Cairo
11835, Cairo
Egypt


Mohamed Zakaria Gad
Biochemistry Department
Faculty of Pharmacy and Biotechnology, German University in Cairo
11835, Cairo
Egypt


Asmaa Mostafa
Department of Internal Medicine III
University Hospital RWTH Aachen, Pauwelsstraße 30, 52074
Aachen
Germany
/
Department of Microbial Biotechnology
Division of Genetic Engineering and Biotechnology, National Research Center, 33 El-Bohouth St., El-Dokki, 12622
Giza
Egypt


Matthias Bartneck
Department of Internal Medicine III
University Hospital RWTH Aachen, Pauwelsstraße 30, 52074
Aachen
Germany


Beatriz B. Oliveira
UCIBIO, Life Sciences Department
Faculdade de Ciências e Tecnologia, Campus de Caparica
2829-516 Caparica
Portugal


Alexandra R. Fernandes
UCIBIO, Life Sciences Department
Faculdade de Ciências e Tecnologia, Campus de Caparica
2829-516 Caparica
Portugal


Pedro V. Baptista
UCIBIO, Life Sciences Department
Faculdade de Ciências e Tecnologia, Campus de Caparica
2829-516 Caparica
Portugal


Seda Keleştemur
University of Health Sciences
Institution of Health Sciences, Department of Biotechnology
Tıbbiye Cad., 34668, Istanbul
Turkey


Gamze Kuku
Yeditepe University
Faculty of Engineering, Department of Genetics and Bioengineering
Kayısdagı Cad., 34755, Istanbul
Turkey


Turkan Ikizceli
Department of Radiology
University of Health Sciences Turkey, Haseki Training and Research Hospital
Istanbul
Turkey


S. Karacavus
Department of Nuclear Medicine
University of Health Sciences Turkey, Kayseri City Training and Research Hospital
Kayseri
Turkey




RELATED BOOKS

.Topics in Anti-Cancer Research.
.Frontiers in Clinical Drug Research - Anti-Cancer Agents.
.The Evolution of Radionanotargeting towards Clinical Precision Oncology: A Festschrift in Honor of Kalevi Kairemo.
.Modern Cancer Therapies and Traditional Medicine: An Integrative Approach to Combat Cancers.